JAMES AGRESTI: Open Payments
NPI 1578511135 · NUTLEY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 52 payments from 20 companies in 2025. Trend: 2023 $1,250 · 2024 $1,078 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $113 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Exact Sciences Corporation | 3 | $70 |
| Kowa Pharmaceuticals America, Inc. | 4 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| Axsome Therapeutics, Inc. | 4 | $59 |
| Lundbeck LLC | 3 | $53 |
| Astellas Pharma US Inc | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
Products named: REXULTI, MOUNJARO, Cologuard Collection Kit, ZORYVE, JARDIANCE, Auvelity, Veozah, KISUNLA.
Industry payments across NJ — which companies pay providers there.
